Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways

Journal of Hepatology - Tập 57 - Trang 577-583 - 2012
Chunmei Wang1, Salvatore Delogu2, Coral Ho1, Susie A. Lee1, Bing Gui1, Lijie Jiang1, Sara Ladu3, Antonio Cigliano2, Frank Dombrowski2, Matthias Evert2, Diego F. Calvisi2, Xin Chen1,4
1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, USA
2Institute of Pathology, University of Greifswald, Greifswald, Germany
3Department of Medicine and Aging, University of Chieti, Chieti, Italy
4Liver Center, University of California, San Francisco, USA

Tài liệu tham khảo